Potential Implication of Paxillin in Cancer Establishment Within the Bone Environment (original) (raw)
The hidden role of paxillin: localization to nucleus promotes tumor angiogenesis
Sunila Pradeep
Oncogene, 2020
View PDFchevron_right
Diverse roles for the paxillin family of proteins in cancer
Jeanine Pignatelli
Genes & cancer, 2012
View PDFchevron_right
Dynamic redistribution of paxillin in bovine osteoblasts stimulated with adenosine 5′-triphosphate
David Mazzochi-jones
Journal of Molecular Histology, 2012
View PDFchevron_right
Evaluation of paxillin expression in patients with oral squamous cell carcinoma: An immunohistochemical study
Saurabh Shekhar
Journal of Oral and Maxillofacial Pathology, 2017
View PDFchevron_right
Paxillin Regulates Androgen- and Epidermal Growth Factor-induced MAPK Signaling and Cell Proliferation in Prostate Cancer Cells
Katherine J O'Malley
Journal of Biological Chemistry, 2010
View PDFchevron_right
Paxillin Is a Target for Somatic Mutations in Lung Cancer: Implications for Cell Growth and Invasion
zumba zumba
View PDFchevron_right
Paxillin serine 178 phosphorylation in control of cell migration and metastasis formation through regulation of EGFR expression in breast cancer
Marjo Graauw
Journal of Cancer Metastasis and Treatment
View PDFchevron_right
Paxillin expression and amplification in early lung lesions of high-risk patients, lung adenocarcinoma and metastatic disease
Loren Joseph
Journal of Clinical Pathology, 2010
View PDFchevron_right
Expression of the Focal Adhesion Protein Paxillin in Normal and Breast Cancer Tissues
Danila D
Veterinary Research Communications, 2003
View PDFchevron_right
Differential Phosphorylation of Paxillin in Response to Surface-Bound Serum Proteins during Early Osteoblast Adhesion
Clinton Rubin
Biochemical and Biophysical Research Communications, 2001
View PDFchevron_right
Bone tissue as the site of action of oncological drugs
M. Litwiniuk
Współczesna Onkologia, 2011
View PDFchevron_right
Paxillin controls endothelial cell migration and tumor angiogenesis by altering neuropilin 2 expression
Donald Ingber
Journal of Cell Science, 2014
View PDFchevron_right
Paxillin localisation in osteocytes—Is it determined by the direction of loading?
Cornelis Semeins
Biochemical and Biophysical Research Communications, 2008
View PDFchevron_right
Paxillin phosphorylation sites mapped by mass spectrometry
Cynthia Brame
View PDFchevron_right
Pathophysiology and Pharmacological Targeting of Tumor-Induced Bone Disease: Current Status and Emerging Therapeutic Interventions
Spyros Skandalis
Current Medicinal Chemistry, 2011
View PDFchevron_right
Involvement of the Paxillin Pathway in JB6 Cl41 Cell Transformation
Hong Suk Choi
Cancer Research, 2006
View PDFchevron_right
Cytoplasmic cyclin D1 regulates cell invasion and metastasis through the phosphorylation of paxillin
Tània Cemeli
Nature communications, 2016
View PDFchevron_right
Reduced paxillin expression contributes to the antimetastatic effect of 4-hydroxycoumarin on B16-F10 melanoma cells
Nohemi Mendoza
Cancer Cell International, 2008
View PDFchevron_right
Tasquinimod inhibits prostate cancer growth in bone through alterations in the bone microenvironment
Karin Welén
The Prostate, 2015
View PDFchevron_right
Paclitaxel inhibits osteoclast formation and bone resorption via influencing mitotic cell cycle arrest and RANKL-induced activation of NF-κB and ERK
Robin Scaife
Journal of Cellular Biochemistry, 2012
View PDFchevron_right
Paxillin promotes colorectal tumor invasion and poor patient outcomes via ERK-mediated stabilization of Bcl-2 protein by phosphorylation at Serine 87
Chi Chou Huang
Oncotarget, 2015
View PDFchevron_right
Meeting report from the IX international meeting on cancer induced bone disease
John Chirgwin
IBMS BoneKEy, 2010
View PDFchevron_right
Bone microenvironment-related growth factors modulate differentially the anticancer actions of zoledronic acid and doxorubicin on PC-3 prostate cancer cells
Menelaos N . Manoussakis, Michael Koutsilieris
The Prostate, 2004
View PDFchevron_right
Effects of Bone-Targeted Agents on Cancer Progression and Mortality
Philippe Clézardin
JNCI Journal of the National Cancer Institute, 2012
View PDFchevron_right
Modulation of Bone Microenvironment with Zoledronate Enhances the Therapeutic Effects of STI571 and Paclitaxel against Experimental Bone Metastasis of Human Prostate Cancer
Sertac Yazici
Cancer Research, 2005
View PDFchevron_right
Expression of the focal adhesion protein paxillin in lung cancer and its relation to cell motility
Darren Ewaniuk
Oncogene, 1999
View PDFchevron_right
Docetaxel inhibits bone resorption through suppression of osteoclast formation and function in different manners
Nobuyuki Udagawa, Yuko Nakamichi
Journal of Bone and Mineral Metabolism, 2009
View PDFchevron_right